Market Cap

Portage Biotech, Inc. Market Capitalization:

$1.7 Million

USD as of Jan. 1, 2026

business Portage Biotech, Inc. Company Profile

Portage Biotech, Inc. Main Stock Listing

NASDAQ: PRTG

Market Capitalization History of Portage Biotech, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Portage Biotech, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.7 M -62.06%
Jan. 1, 2025 $4.6 M -78.68%
Jan. 1, 2024 $21.6 M -75.94%
Jan. 1, 2023 $89.6 M -37.67%
Jan. 1, 2022 $143.7 M -61.41%
Jan. 1, 2021 $372.4 M 95.57%
Jan. 1, 2020 $190.4 M 27.78%
Jan. 1, 2019 $149.0 M 30.43%
Jan. 1, 2018 $114.3 M -58.18%
Jan. 1, 2017 $273.3 M 60.19%
Jan. 1, 2016 $170.6 M 3.00%
Jan. 1, 2015 $165.6 M -44.44%
Jan. 1, 2014 $298.1 M 45.16%
Jan. 1, 2013 $205.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Portage Biotech, Inc. Categories

languages Healthcare languages Biotechnology

Stocks & Indices

Portage Biotech, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PRTG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.